Animal Medicine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240805

Publication Date:

September 24, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Veterinary medicine听is the branch of听medicine听that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human听animals. The scope of veterinary medicine is wide, covering all animal species, both听domesticated听and听wild, with a wide range of conditions which can affect different species.
The global market for Animal Medicine was estimated to be worth US$ 23520 million in 2023 and is forecast to a readjusted size of US$ 33280 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Medicine by region & country, by Type, and by Application.
The Animal Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Medicine.
麻豆原创 Segmentation
By Company
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Segment by Type:
Oral
Injection
Other
Segment by Application
Companion Animals
Livestock Animals
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Animal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Animal Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Animal Medicine Product Introduction
1.2 Global Animal Medicine 麻豆原创 Size Forecast
1.3 Animal Medicine 麻豆原创 Trends & Drivers
1.3.1 Animal Medicine Industry Trends
1.3.2 Animal Medicine 麻豆原创 Drivers & Opportunity
1.3.3 Animal Medicine 麻豆原创 Challenges
1.3.4 Animal Medicine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Medicine Players Revenue Ranking (2023)
2.2 Global Animal Medicine Revenue by Company (2019-2024)
2.3 Key Companies Animal Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Animal Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Animal Medicine
2.6 Animal Medicine 麻豆原创 Competitive Analysis
2.6.1 Animal Medicine 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Animal Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.1.3 Other
3.2 Global Animal Medicine Sales Value by Type
3.2.1 Global Animal Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Animal Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Companion Animals
4.1.2 Livestock Animals
4.2 Global Animal Medicine Sales Value by Application
4.2.1 Global Animal Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Animal Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Animal Medicine Sales Value by Region
5.1.1 Global Animal Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Medicine Sales Value by Region (2019-2024)
5.1.3 Global Animal Medicine Sales Value by Region (2025-2030)
5.1.4 Global Animal Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Animal Medicine Sales Value, 2019-2030
5.2.2 North America Animal Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Animal Medicine Sales Value, 2019-2030
5.3.2 Europe Animal Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Animal Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Animal Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Animal Medicine Sales Value, 2019-2030
5.5.2 South America Animal Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Animal Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Animal Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Medicine Sales Value
6.3 United States
6.3.1 United States Animal Medicine Sales Value, 2019-2030
6.3.2 United States Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Medicine Sales Value, 2019-2030
6.4.2 Europe Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Medicine Sales Value, 2019-2030
6.5.2 China Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Medicine Sales Value, 2019-2030
6.6.2 Japan Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Medicine Sales Value, 2019-2030
6.7.2 South Korea Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Medicine Sales Value, 2019-2030
6.9.2 India Animal Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Profile
7.1.2 Boehringer Ingelheim Main Business
7.1.3 Boehringer Ingelheim Animal Medicine Products, Services and Solutions
7.1.4 Boehringer Ingelheim Animal Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 Boehringer Ingelheim Recent Developments
7.2 Zoetis
7.2.1 Zoetis Profile
7.2.2 Zoetis Main Business
7.2.3 Zoetis Animal Medicine Products, Services and Solutions
7.2.4 Zoetis Animal Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Zoetis Recent Developments
7.3 Elanco Animal Health
7.3.1 Elanco Animal Health Profile
7.3.2 Elanco Animal Health Main Business
7.3.3 Elanco Animal Health Animal Medicine Products, Services and Solutions
7.3.4 Elanco Animal Health Animal Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Animal Health Recent Developments
7.4 Merck Animal Health
7.4.1 Merck Animal Health Profile
7.4.2 Merck Animal Health Main Business
7.4.3 Merck Animal Health Animal Medicine Products, Services and Solutions
7.4.4 Merck Animal Health Animal Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Animal Health Recent Developments
7.5 Virbac
7.5.1 Virbac Profile
7.5.2 Virbac Main Business
7.5.3 Virbac Animal Medicine Products, Services and Solutions
7.5.4 Virbac Animal Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Virbac Recent Developments
7.6 Dechra Veterinary Products
7.6.1 Dechra Veterinary Products Profile
7.6.2 Dechra Veterinary Products Main Business
7.6.3 Dechra Veterinary Products Animal Medicine Products, Services and Solutions
7.6.4 Dechra Veterinary Products Animal Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 Dechra Veterinary Products Recent Developments
7.7 Ceva
7.7.1 Ceva Profile
7.7.2 Ceva Main Business
7.7.3 Ceva Animal Medicine Products, Services and Solutions
7.7.4 Ceva Animal Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Ceva Recent Developments
7.8 Vetoquinol
7.8.1 Vetoquinol Profile
7.8.2 Vetoquinol Main Business
7.8.3 Vetoquinol Animal Medicine Products, Services and Solutions
7.8.4 Vetoquinol Animal Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 Vetoquinol Recent Developments
7.9 Meiji
7.9.1 Meiji Profile
7.9.2 Meiji Main Business
7.9.3 Meiji Animal Medicine Products, Services and Solutions
7.9.4 Meiji Animal Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Meiji Recent Developments
7.10 Ouro Fino Saude
7.10.1 Ouro Fino Saude Profile
7.10.2 Ouro Fino Saude Main Business
7.10.3 Ouro Fino Saude Animal Medicine Products, Services and Solutions
7.10.4 Ouro Fino Saude Animal Medicine Revenue (US$ Million) & (2019-2024)
7.10.5 Ouro Fino Saude Recent Developments
7.11 Animalcare Group
7.11.1 Animalcare Group Profile
7.11.2 Animalcare Group Main Business
7.11.3 Animalcare Group Animal Medicine Products, Services and Solutions
7.11.4 Animalcare Group Animal Medicine Revenue (US$ Million) & (2019-2024)
7.11.5 Animalcare Group Recent Developments
7.12 Parnell
7.12.1 Parnell Profile
7.12.2 Parnell Main Business
7.12.3 Parnell Animal Medicine Products, Services and Solutions
7.12.4 Parnell Animal Medicine Revenue (US$ Million) & (2019-2024)
7.12.5 Parnell Recent Developments
8 Industry Chain Analysis
8.1 Animal Medicine Industrial Chain
8.2 Animal Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Animal Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.